If you are looking for the best Build A Boat For Treasure scripts to use on mobile or PC to get QoL features like auto farm, auto buy, auto build, and several others to make sure you are progressing i ...

The powerful teachers’ union delivered a master class in wheeling and dealing — winning pay bumps of up to $9,500 as part of a deal delaying New York’s class size mandate. Under a compromise, the ...

YouTube content creation often feels like a guessing game, but a new strategy empowers creators to use ChatGPT for data-driven success. The AI transforms instinct into evidence by analyzing competitor ...

EXCLUSIVE: Veteran literary scout Philippa Donovan wants to reverse engineer the books-to-screen market through her new business, Two Script Studio. The operation will create ‘reverse adaptations‘ to ...

The app, which allows casts and crews to mark up and revise scripts digitally, has diverted more than 120 million sheets from production sets worldwide over the past three years. By Kirsten Chuba ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...